| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.
|
Antimicrob Agents Chemother
|
1996
|
6.01
|
|
2
|
Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids.
|
Infect Immun
|
1984
|
3.98
|
|
3
|
Novel mechanism of macrolide resistance in Streptococcus pneumoniae.
|
Diagn Microbiol Infect Dis
|
1996
|
3.29
|
|
4
|
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori.
|
Antimicrob Agents Chemother
|
1997
|
2.63
|
|
5
|
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.
|
J Antimicrob Chemother
|
1997
|
2.47
|
|
6
|
Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.
|
Clin Infect Dis
|
1999
|
2.16
|
|
7
|
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.
|
Helicobacter
|
1996
|
2.10
|
|
8
|
Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2000
|
1.47
|
|
9
|
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism.
|
J Clin Microbiol
|
1997
|
1.37
|
|
10
|
Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
|
Antimicrob Agents Chemother
|
1991
|
1.30
|
|
11
|
Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
|
Microb Drug Resist
|
1999
|
1.30
|
|
12
|
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
|
Antimicrob Agents Chemother
|
2001
|
1.02
|
|
13
|
Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
|
J Med Chem
|
2000
|
1.01
|
|
14
|
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
|
Antimicrob Agents Chemother
|
2001
|
0.97
|
|
15
|
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
|
J Med Chem
|
1998
|
0.86
|
|
16
|
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH.
|
J Clin Microbiol
|
1997
|
0.84
|
|
17
|
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin.
|
Epidemiol Infect
|
1997
|
0.80
|
|
18
|
3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activity.
|
J Antibiot (Tokyo)
|
1996
|
0.79
|
|
19
|
PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial.
|
J Antimicrob Chemother
|
1997
|
0.79
|
|
20
|
In vitro activity of A-192411.29, a novel antifungal lipopeptide.
|
Antimicrob Agents Chemother
|
2000
|
0.75
|
|
21
|
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
|
J Med Chem
|
1998
|
0.75
|
|
22
|
Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position.
|
J Med Chem
|
1999
|
0.75
|